Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observational study on retained needle fragments in intravenous drug users

Official title: The Prevalence and Predisposing Factors to Retained Drug Needle Fragments in People Who Inject Drugs: a Protocol for a Cross-sectional Observational Study

Run by Tampere University Hospital · NCT05679284 · Data updated 2026-11-12

This study is trying to find out how common it is for people who use intravenous drugs to have leftover pieces of needles in their bodies and what factors might increase this risk.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorTampere University Hospital
Academic / other
Locations1 site (Tampere)
StatusRecruiting
StartedMay 25, 2023
Main results expectedNovember 15, 2027
Study endsNovember 15, 2028
Registry record updatedJune 1, 2023
Trial IDNCT05679284 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a history of intravenous drug use who are currently receiving treatment for their substance dependence.

Probably not a fit

Patients who have never used intravenous drugs or those who are underage or pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to estimate the prevalence of retained needle fragments in people who use intravenous drugs (PWIDs) and identify associated risk factors. Participants will complete a questionnaire regarding their drug use history and injection practices, followed by targeted low-dose X-ray imaging of their injection sites to detect any retained needle fragments. The study seeks to understand the local tissue complications and potential hazards posed by these fragments, which can lead to serious health issues. The research has received ethical approval and aims to provide valuable insights into a largely unstudied aspect of intravenous drug use.

Why it matters

Potential benefit: If successful, this study could improve understanding of the risks associated with intravenous drug use and inform better clinical practices for managing complications.

How similar studies have gone: While there have been case reports on retained needle fragments, this study represents a novel approach to systematically assess the prevalence and risks associated with this condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* History of intravenous drug use
* Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre.
* Adherence to fill in the questionnaire
* Participation to X-ray imaging of injection sites

Exclusion Criteria:

* No history of intravenous drug use
* Does not adhere to fill in the questionnaire or refuses X-ray imaging
* Pregnancy
* Underage (18 years old)

Where it's running

  • Hatanpää Health Center
    Tampere, Finland
    Recruiting

Study contacts

  • Principal investigator: Markku Sumanen, MD-PhD — Tampere University
  • Study coordinator: Otso Arponen, Associate Professor, MD
  • Email: otso.arponen@tuni.fi
  • Phone: +358 50 410 6170

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.